Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer-Reference-Cited by-同舟云学术

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

Published:2018-10 Issue: Volume:124 Page:6-11
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

de Jong Evelyn E.C.^ORCID,van Elmpt Wouter,Rizzo Stefania,Colarieti Anna,Spitaleri Gianluca,Leijenaar Ralph T.H.,Jochems Arthur,Hendriks Lizza E.L.,Troost Esther G.C.,Reymen Bart,Dingemans Anne-Marie C.,Lambin Philippe

Funder

ERC

EFPI A companies and the Innovative Medicine Initiative Joint Undertaking (IMI JU)

Dutch technology Foundation STW

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference27 articles.

1. Is there a causal relationship between genetic changes and radiomics-based image features? An in vivo preclinical experiment with doxycycline inducible GADD34 tumor cells;Panth;Radiother. Oncol.,2015

2. Reproducibility and prognosis of quantitative features extracted from CT images;Balagurunathan;Transl. Oncol.,2014

3. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma;Coroller;Radiother. Oncol.,2015